slides · global inventory
42 Hypothesis Test
Loop collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 1,665
Current window 1,201-1,230
Pages 56
Rows per page 30
Loop
1,201-1,230 of 1,665
07
Includes fiscal period, financial metrics, and operational achievements.Azek | Results Presentation Deck | 22 slides · The AZEK Company
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
08
Includes year-over-year growth percentages and basis point improvements.Azek | Results Presentation Deck | 22 slides · The AZEK Company
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
09
Includes year-over-year growth percentages and basis point changes for key financial metrics.Azek | Results Presentation Deck | 22 slides · The AZEK Company
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
10
The slide uses a side-by-side comparison structure to contrast growth in the Residential segment against decline in the Commercial segment.Azek | Results Presentation Deck | 22 slides · The AZEK Company
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
10
Electronic Arts | Results Presentation Deck | 17 slidesElectronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
11
The table provides a bridge between GAAP guidance ranges and specific adjustments like acquisition-related expenses, restructuring, and stock-based compensation.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
12
The table provides a bridge between GAAP guidance and specific adjustments like acquisition-related experiences, deferred revenue, and stock-based compensation.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
13
Electronic Arts | Results Presentation Deck | 17 slidesElectronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
07
The chart uses a waterfall bridge format to explain the variance in ACL over the year.Hilltop Holdings | Results Presentation Deck | 22 slides · Hilltop Holdings
Conference presentation Investor relations Beat · What IsLoop · Hypothesis Test1 hit
15
The slide uses a visual comparison to highlight a 67% improvement in response rates for NXC-201 compared to competitors.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Evidence & ProofLoop · Hypothesis Test1 hit
16
Includes a footer citing FDA approval precedents for similar single-arm studies.Immix Biopharma | Investor Presentation Deck | 57 slides · Immix Biopharma
Pitch deck Investor relations Beat · Evidence & ProofLoop · Hypothesis Test1 hit
50
The slide uses a grid of cards to present qualitative and quantitative data points about the data infrastructure.Innovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations Loop · Hypothesis Test1 hit
51
The diagram illustrates a data-driven flywheel or feedback loop process.Innovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations Loop · Hypothesis Test1 hit
06
The slide outlines a deal structure involving upfront payments, milestones, royalties, and a division of development labor.Legend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
13
The slide uses dot plots to show IC50 values for different drugs across fusion partners and mutations, and a bar chart to show tumor regression efficacy.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
14
The chart on the right uses a log scale for the y-axis to visualize selectivity indices.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
15
The slide uses a side-by-side comparison framework to delineate the two phases of the clinical trial.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
16
The slide details the patient population (N=35) and the subset of response-evaluable patients (N=21) across five dose cohorts.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
17
The data highlights a heavily pretreated population, with 77% having received 3 or more prior lines of therapy.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
18
Data as of 13 Sep 22. N=35 patients.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
19
The chart displays dose-dependent exposure over 24 hours, with horizontal dashed lines representing efficacy targets for different ROS1 variants in CNS and periphery.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
20
Clinical trial data table showing efficacy metrics for NVL-520.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
10
The chart shows a consistent upward trend in both GOV and Revenue over the 7-quarter period.Vivid Seats | Results Presentation Deck | 22 slides · Vivid Seats
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
11
Includes footnotes regarding non-GAAP reconciliation and noncontrolling interests.Vivid Seats | Results Presentation Deck | 22 slides · Vivid Seats
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
12
The table uses upward-pointing arrows to indicate positive changes in guidance over time.Vivid Seats | Results Presentation Deck | 22 slides · Vivid Seats
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
13
Includes a disclaimer regarding non-GAAP financial measures and a footnote defining YOY growth.Vivid Seats | Results Presentation Deck | 22 slides · Vivid Seats
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
04
Includes a footnote regarding the date of the cash position.Yatsen | Results Presentation Deck | 15 slides · Yatsen
Conference presentation Investor relations Beat · AttentionLoop · Hypothesis Test1 hit
05
Data sourced from China National Bureau of Statistics (CNBS).Yatsen | Results Presentation Deck | 15 slides · Yatsen
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
06
Yatsen | Results Presentation Deck | 15 slidesYatsen | Results Presentation Deck | 15 slides · Yatsen
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
07
The slide highlights a shift in revenue mix towards skincare brands despite a slight YoY decline in absolute revenue.Yatsen | Results Presentation Deck | 15 slides · Yatsen
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit